News from isoplexis A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Oct 03, 2019, 08:30 ET IsoPlexis' New Software & Applications Pave the Way for Novel Functional Understanding of Single-Cell Immune Activation and Further Application Expansion

IsoPlexis, the leader in single-cell functional proteomics, today launched its IsoSpeak Software for automated on-site analysis and advanced,...


Sep 30, 2019, 10:30 ET IsoPlexis' Immune Monitoring Contributions in Precision Medicine Highlighted in Comprehensive Publication, "Biomarkers for Immunotherapy of Cancer"

IsoPlexis, the leader in single-cell functional proteomics, continues to accelerate immunotherapy development with its IsoLight system, which was...


Sep 26, 2019, 08:30 ET IsoPlexis Continues Progress on Precision CAR-T cell Characterization with Recent Data Sets & Miltenyi Biotec, Inc. Technology Note

IsoPlexis, the leader in single-cell functional proteomics, continues to build upon recent success in the CAR-T field through NCI funding, advanced...


Sep 19, 2019, 09:00 ET IsoPlexis Announces Partnership with BioStream & IsoLight Expansion into Japanese Life Science Market

IsoPlexis, the leader in single-cell functional proteomics products, today announced an exclusive agreement with BioStream Co, a leading distributor...


Aug 01, 2019, 09:00 ET IsoPlexis Launches First European Office & Initial IsoLight Single Cell Cytokine Detection System at Karolinska Institute in Sweden

IsoPlexis, the leading life sciences company in the single-cell functional biology space, has installed its innovative IsoLight single cell cytokine...


Jun 21, 2019, 09:00 ET IsoPlexis Receives $4 Million National Cancer Institute Grant for Commercialization of IsoLight for CAR-T Functional Quality Profiling

IsoPlexis, a company focused on advancing single-cell functional biomarkers to address critical challenges in oncology & beyond, today announced that ...


May 14, 2019, 11:44 ET IsoPlexis Completes $25 Million Series C Financing

IsoPlexis, a company focused on advancing single-cell biomarkers to address critical challenges in oncology & beyond, today announced that it had...


Sep 20, 2018, 10:00 ET Early Access to IsoPlexis' Single Cell Analytics Platform Enhances Cell Therapy Program at World-renowned Research and Treatment Center

The IsoLight® platform: profiles responses at the single cell level enabling researchers to generate a precise functional patient signature to help...


Aug 20, 2018, 17:00 ET IsoPlexis Announces Expansion into Asia Pacific

IsoPlexis Corporation (IsoPlexis), a privately held life sciences company at the forefront of single-cell analytics technology, announced today an...


Jul 24, 2018, 08:00 ET IsoPlexis Places IsoLight Single-Cell Proteomic Detection Instrument at Fred Hutchinson Cancer Research Center

IsoPlexis Corporation (IsoPlexis), a privately held life sciences company at the forefront of single-cell analytics technology, has installed its...


Jun 26, 2018, 08:00 ET IsoPlexis Announces Research Collaboration with Nektar Therapeutics

IsoPlexis Corporation (IsoPlexis), a privately held life sciences company at the forefront of single-cell analytics technology, announced today its...


Jun 12, 2018, 04:01 ET Clinical Data Highlighting Single-Cell Polyfunctionality as a Potential Predictor of Patient Response to CAR-T Cell Therapy Published in "Blood"

IsoPlexis Corporation (IsoPlexis) today announced the publication of clinical data demonstrating a significant association between the functionality...


May 15, 2018, 11:41 ET IsoPlexis Recognized with the Pharma Tech Outlook Cover Story as Top 10 Analytics Solution Provider in 2018

IsoPlexis has been recognized with Pharma Tech Outlook's cover story for the top 10 analytics solution providers in 2018. The award focuses on...